u/GranchioDiTerra

Been a while since I posted here. Wanted to come back to something I've mentioned in comments but never properly laid out: why I keep coming back to the barrier in everything I write.

I'm a patient with about 10 years of LS history. Currently stable, post-circumcision, residual white patches that slowly spread when I'm not careful. Not a medical professional. Not medical advice.

For anyone who's seen me reply in threads, you know I lean heavily on barrier work. Corticosteroids are the foundation of LS treatment and work powerfully on the inflammatory process, but they don't address every aspect of the disease. The barrier is one of the things that sits outside what they do, and on LS tissue it's not just a comfort issue. It's the layer that decides whether ordinary friction reaches immune-active tissue or gets buffered before it does. Barrier work runs alongside the prescribed treatment, covering ground it isn't designed to cover.

The specific finding that changed how I think about products came from Elias 2005, a stratum corneum biology review. When the barrier is acutely disrupted, applying only one or two of the three essential stratum corneum lipids (ceramides, cholesterol, free fatty acids) actually slows recovery compared to applying nothing. Applying all three together restores normal recovery. Skewing one of the three to roughly three times the level of the other two accelerates recovery further, with which lipid should be at the 3 depending on what the tissue is most depleted in. Atopic dermatitis is ceramide-deficient, so ceramide-dominant mixtures work there. Aged skin is cholesterol-deficient, so cholesterol-dominant mixtures work there. For LS specifically, there isn't published lipid profiling that tells us which of the three is most depleted, so the honest reading is that all three should be present without claiming any one is dominant.

Important caveat: Elias tested acutely barrier-disrupted skin in rodents and young human subjects, using purified lipid mixtures in controlled ratios. That's not the same as commercial cosmetic products applied daily to chronic LS tissue. The 1:1:1 / 3:1:1 ratios are a principle for thinking about barrier biology, not a proof that any specific commercial product hits an optimal mixture. And the "one or two lipids delays recovery" finding is specific to acute disrupted skin. It doesn't establish that daily use of a partial-lipid product is a net negative in chronic LS management. The translation from Elias's laboratory findings to product effectiveness in LS is an extension the paper doesn't make.

The other Elias finding worth knowing is the recovery timeline. Young healthy skin recovers in about 12 hours initially with a later phase running to around 72 hours. Aged skin can take over a week. LS tissue isn't measured in that paper, but given the chronic inflammatory state my working assumption is that it sits closer to the aged-skin end. A friction event Tuesday isn't recovered by Wednesday morning. The barrier is in active repair for days, and what you put on it during that window isn't trivial.

This shaped how I read product labels. All three lipid classes if possible, no fragrance, minimal preservative load, no vehicle ingredients flagged in the EuroGuiDerm 2024 guideline. Two products I've mentioned in comments illustrate the trade-off. Ceramol Beta Crema Intima is the closer match in strict Elias terms, with ceramides, real cholesterol, and stearic acid as a free fatty acid, but it's an aqueous formulation with a multi-preservative system. VEA Lipo 3 contains all three lipid families (ceramides, fatty acids in triglyceride form, and phytosterols as a cholesterol-class lipid), in an anhydrous, seven-ingredient, preservative-free formulation. The chemical forms in VEA aren't a perfect match for Elias's purified mixtures, but triglyceride-based fatty acid delivery is the standard approach in cosmetic emollients and may behave differently in chronic daily use than Elias's acute experiments measured. Different trade-offs, neither one a verified Elias match in the experimental sense. Neither is the only option, and neither is perfect.

None of this replaces what your specialist has you doing for active flares. The products I named are not a recommendation. Every LS patient reacts differently to any given formulation, and product INCI lists change over time, by region, and sometimes by batch. The same brand name on a shelf two years from now may not have the same composition. The principle (knowing what lipid classes you want, knowing what vehicle ingredients to avoid) is what carries across products and time.

I'm a patient sharing experience and what I've understood from the research, not medical advice. Every specific decision about your care requires clinical judgment from a specialist who knows your situation.

Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005. https://pubmed.ncbi.nlm.nih.gov/16098026/